Abstract: Time Savings with Trastuzumab Subcutaneous (SC) Injection vs. Trastuzumab Intravenous (IV) Infusion: A Time and Motion Study in 3 Russian Centres

 

Abstract: Time Savings with Trastuzumab Subcutaneous (SC) Injection vs. Trastuzumab Intravenous (IV) Infusion: A Time and Motion Study in 3 Russian Centres

Trastuzumab (TRA) subcutaneous (SC) injection is an alternative to intravenous (IV) administration for the treatment of HER2+ early breast cancer (EBC). The objective was to quantify healthcare professional (HCP) time and patient chair time related to TRA treatment to estimate potential time and cost savings with a transition from IV to SC.